Selective Serotonin Reuptake Inhibitors and Nutraceutical Combination in Major Depression Disorder: A Case-Control Study

Name: Selective Serotonin Reuptake Inhibitors and Nutraceutical Combination in Major Depression Disorder: A Case-Control Study
SKU: 24685
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 51 No. 4 Articles 2021 Tags: Camilla Callegari, cgi, depression, Francesca Ceccon, HADS, Ivano Caselli, Marcello Diurni, Marta Ielmini, Nicola Poloni, nutraceuticals, nutraceuticals co-prescribing, PGI-I, ssris

Description

Description

Original Research

Selective Serotonin Reuptake Inhibitors and Nutraceutical Combination in Major Depression Disorder: A Case-Control Study

Marta Ielmini, Ivano Caselli, Francesca Ceccon, Marcello Diurni, Nicola Poloni, Camilla Callegari

Selective Serotonin Reuptake Inhibitors and Nutraceutical Combination in Major Depression Disorder: A Case-Control Study

Description

Original Research

Long-Term Antidepressant Treatment

Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine

New Developments in the Neurobiological Basis of Anxiety Disorders

Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

Selective Serotonin Reuptake Inhibitors and Nutraceutical Combination in Major Depression Disorder: A Case-Control Study

Description

Original Research

Related products

Long-Term Antidepressant Treatment

Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine

New Developments in the Neurobiological Basis of Anxiety Disorders

Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials